65
Registered trials
28
Recruiting
28
Completed trials
49
Sponsors
24
Countries
Phase III:
25
Phase II/III:
2
Phase II:
15
Phase I/II:
1
Phase III/IV:
1
Phase IV:
20
Other:
1
Oversight events:
3 serious breaches
1 urgent safety measure
2 corrective measures
across 5 trials
View oversight register →
Indications tested
Chronic kidney disease
7
Type 2 diabetes mellitus
3
IgA nephropathy
3
Hypertension
3
Acute myocardial infarction
2
Cardiac failure
2
Obesity
1
Heritable pulmonary arterial hypertension
1
Laboratory test abnormal
1
Glomerulonephritis membranous
1
Pulmonary arterial hypertension
1
Cardiac amyloidosis
1
Sponsors using this IMP
AstraZeneca AB
9
Eli Lilly & Co.
3
Novo Nordisk A/S
3
Odense University Hospital
3
Assistance Publique Hopitaux De Paris
2
Centre Hospitalier Universitaire De Nantes
2
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
2
Oslo University Hospital HF
2
Region Midtjylland
2
Universitaetsmedizin Goettingen
2
4 Wojskowy Szpital Kliniczny Z Polikliniką Samodzielny Publiczny Zaklad Opieki Zdrowotnej We Wroclawiu
1
Aarhus University Hospital
1
All trials — page 2
65 totalShowing 25–48 of 65 trials